Polytimi Sidiropoulou

Dr. Polytimi Sidiropoulou


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
Stamatis GregoriouStamatis Gregoriou
Stamatis Gregoriou
PSPolytimi Sidiropoulou
Polytimi Sidiropoulou
GKGeorgios Kontochristopoulos
Georgios Kontochristopoulos
DRDimitrios Rigopoulos
Dimitrios Rigopoulos
Palmar hyperhidrosis is a potentially disabling condition for which management remains a therapeutic challenge. Given the significant impact on quality of life, various treatment options are available, ranging from topical agents and medical devices to systemic therapies and surgical interventions. Nonsurgical approaches, i.e. topical antiperspirants, botulinum toxin injections, iontophoresis, and systemic agents, are all supported by the current literature. Patients with mild-to-moderate disease can often benefit from topical therapies only. As disease severity progresses, systemic oral medication, such as anticholinergic drugs, usually becomes necessary. Last-line surgical approaches (sympathetic denervation) should be reserved for severe refractory cases. Recently, therapeutic strategies have been evolving with several new agents emerging as promising alternatives in clinical trials. In practice, however, each modality comes with its own benefits and risks. An individual therapeutic ladder is generally recommended, taking into account disease severity, benefit-to-risk profile, treatment cost, patient preference, and clinician expertise. This review will provide an update on current and emerging concepts of management for excessive hand sweating to help clinicians optimize therapeutic decision-making.

31 October 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
EPE. Panou
E. Panou
VNVasiliki A. Nikolaou
Vasiliki A. Nikolaou
LML. Marinos
L. Marinos
SKS. Kallambou
S. Kallambou
PSPolytimi Sidiropoulou
Polytimi Sidiropoulou
ASA. Stratigos
A. Stratigos
We are living an ongoing global COVID-19 pandemic which is associated with a considerable number of fatal cases worldwide1. Vaccines are the promising solution to minimise the problem amongst cancer patients, however there are limitations to be considered such as the efficacy of COVID vaccines for immunocompromised individuals and possible interactions between the vaccine and cancer 3,4,5

17 January 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
NRNATALIA ROMPOTI
NATALIA ROMPOTI
PSPolytimi Sidiropoulou
Polytimi Sidiropoulou
PPPantelis Panagakis
Pantelis Panagakis
ASAlexander Stratigos
Alexander Stratigos
MPMarina Papoutsaki
Marina Papoutsaki
AMAggeliki Mpefon
Aggeliki Mpefon

4 May 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
VNVasiliki A. Nikolaou
Vasiliki A. Nikolaou
APAikaterini Patsatsi
Aikaterini Patsatsi
PSPolytimi Sidiropoulou
Polytimi Sidiropoulou
GCGregory Chlouverakis
Gregory Chlouverakis
EKEirini Kavvalou
Eirini Kavvalou
SKSabine‐Elke Kruger‐Krasagakis
Sabine‐Elke Kruger‐Krasagakis

25 June 2018 in Skin Appendage Disorders
Verified
Journal Article
Open access
PSPolytimi Sidiropoulou
Polytimi Sidiropoulou
DSDimitrios Sgouros
Dimitrios Sgouros
ΚΘΚΩΝΣΤΑΝΤΙΝΟΣ ΘΕΟΔΩΡΟΠΟΥΛΟΣ
ΚΩΝΣΤΑΝΤΙΝΟΣ ΘΕΟΔΩΡΟΠΟΥΛΟΣ
Alexander C. KatoulisAlexander C. Katoulis
Alexander C. Katoulis
DRDimitrios Rigopoulos
Dimitrios Rigopoulos
Onychotillomania, or nail-picking disorder, is an uncommon and misdiagnosed behavioral pattern focused on the nail apparatus. It is demarcated by the compulsive or irresistible urge in patients to constantly injure their own nails, with the fingers or tools, inflicting noticeable or even irreversible self-destruction of the nail unit. Despite its rarity, this self-injurious coercion often poses a diagnostic and therapeutic challenge. Not only do many patients deny nail manipulation, but also the disorder has long been recognized to present itself with a wide range of clinical features, which hampers early and indisputable diagnosis. Furthermore, onychotillomania constitutes a persistent and hardly manageable problem, mostly because of its psychocutaneous nature as well as its high propensity to coexist with underlying neuropsychiatric illnesses or other behavioral disorders. However, the medical literature concerning obsessive nail picking still remains relatively scarce. Herein, we present an extraordinary, yet very intriguing case of a Caucasian patient with onychotillomania and onychophagia coexistence masquerading a weird inflammation-like lesion.

9 October 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Christos SachpekidisChristos Sachpekidis
Christos Sachpekidis
PSPolytimi Sidiropoulou
Polytimi Sidiropoulou
Jessica HasselJessica Hassel
Jessica Hassel
Nikolaos DrakoulisNikolaos Drakoulis
Nikolaos Drakoulis
Antonia Dimitrakopoulou-StraussAntonia Dimitrakopoulou-Strauss
Antonia Dimitrakopoulou-Strauss
Merkel cell carcinoma (MCC) is a rare neuroendocrine skin malignancy usually arising as a nonspecific nodule on sun-exposed areas of the head and neck. Given the poor prognosis of this aggressive tumor, assessment of disease burden in pre- and post-treatment care may ensure an optimal management with significant implications for patient surveillance and prognosis. Although imaging has established its role in locally advanced or distant metastatic MCC, a standard imaging algorithm is yet to be determined and respective recommendations are mainly based on melanoma. Positron emission tomography/computed tomography (PET/CT) is increasingly evolving as a valuable imaging tool in metastatic or unresectable MCC, mostly utilizing the glucose analogue 18F-fluorodeoxyglucose (18F-FDG) as a radiotracer. Despite being inferior in detecting the disease in its early stages compared to the “gold standard” of sentinel lymph node biopsy, recent evidence suggests an important role for 18F-FDG PET/CT in the routine workup of localized MCC. Moreover, 68Ga-labeled somatostatin analogues have been employed as PET tracers in the field of MCC with promising, yet comparable to 18F-FDG, results. This article provides a structured literature review of the most important studies investigating the role of PET or PET/CT in the clinical practice of MCC.